ROTHBLATT MARTINE A bought UTHR
April 21, 2026 · Form 4 insider transaction
ROTHBLATT MARTINE A bought 2,000 shares of United Therapeutics Corporation at $146.03 per share, a transaction worth $292.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$146.03
Total value
$292.1K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 21, 2026
Filing dateApril 22, 2026
Shares owned after50,013
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.